263 related articles for article (PubMed ID: 32811613)
21. Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.
Cappellari M; Moretto G; Micheletti N; Donato F; Tomelleri G; Gulli G; Carletti M; Squintani GM; Zanoni T; Ottaviani S; Romito S; Tommasi G; Musso AM; Deotto L; Gambina G; Zimatore DS; Bovi P
J Thromb Thrombolysis; 2014 May; 37(4):549-56. PubMed ID: 23943338
[TBL] [Abstract][Full Text] [Related]
22. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
[TBL] [Abstract][Full Text] [Related]
23. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
24. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
Zhang B; Sun XJ; Ju CH
Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
[TBL] [Abstract][Full Text] [Related]
25. Identification of Corticospinal Tract Lesion for Predicting Outcome in Small Perfusion Stroke.
Zhou Y; Zhang R; Yan S; Zhang M; Chen Z; Hu H; Zhang M; Bivard A; Lin L; Parsons MW; Lou M
Stroke; 2018 Nov; 49(11):2683-2691. PubMed ID: 30355191
[TBL] [Abstract][Full Text] [Related]
26. A Retrospective Analysis of Ischemic Stroke Patients Supports That Very Early Mobilization Within 24 Hours After Intravenous Alteplase Is Safe and Possibly Beneficial.
Yanase L; Clark D; Baraban E; Stuchiner T
J Neurosci Nurs; 2023 Dec; 55(6):188-193. PubMed ID: 37815279
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes and safety profile of Tenecteplase in wake-up stroke.
Ahmed HK; Logallo N; Thomassen L; Novotny V; Mathisen SM; Kurz MW
Acta Neurol Scand; 2020 Nov; 142(5):475-479. PubMed ID: 32511749
[TBL] [Abstract][Full Text] [Related]
28. CLOTBUST-Hands Free: pilot safety study of a novel operator-independent ultrasound device in patients with acute ischemic stroke.
Barreto AD; Alexandrov AV; Shen L; Sisson A; Bursaw AW; Sahota P; Peng H; Ardjomand-Hessabi M; Pandurengan R; Rahbar MH; Barlinn K; Indupuru H; Gonzales NR; Savitz SI; Grotta JC
Stroke; 2013 Dec; 44(12):3376-81. PubMed ID: 24159060
[TBL] [Abstract][Full Text] [Related]
29. Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis - data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
Che F; Wang A; Ju Y; Ding Y; Duan H; Geng X; Zhao X; Wang Y
BMC Neurol; 2022 Jun; 22(1):212. PubMed ID: 35672740
[TBL] [Abstract][Full Text] [Related]
30. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
31. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
[TBL] [Abstract][Full Text] [Related]
32. Comparison of thrombolytic agents in treatment of patients with acute ischemic stroke; findings from a single centre follow up study in real-life settings.
George M; Baby N; Paul R; Zabeer M; Thomas C
J Clin Neurosci; 2021 Sep; 91():299-305. PubMed ID: 34373043
[TBL] [Abstract][Full Text] [Related]
33. Intravenous Alteplase Treatment of Acute Ischemic Stroke Patients Exhibiting Mild Neurological Deficits.
Sun J; Wang H; Sun M; Xie Q; Liu N; Wang M
J Coll Physicians Surg Pak; 2022 Mar; 32(3):352-358. PubMed ID: 35148589
[TBL] [Abstract][Full Text] [Related]
34. Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection.
Ringleb P; Bendszus M; Bluhmki E; Donnan G; Eschenfelder C; Fatar M; Kessler C; Molina C; Leys D; Muddegowda G; Poli S; Schellinger P; Schwab S; Serena J; Toni D; Wahlgren N; Hacke W;
Int J Stroke; 2019 Jul; 14(5):483-490. PubMed ID: 30947642
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
Parsons M; Spratt N; Bivard A; Campbell B; Chung K; Miteff F; O'Brien B; Bladin C; McElduff P; Allen C; Bateman G; Donnan G; Davis S; Levi C
N Engl J Med; 2012 Mar; 366(12):1099-107. PubMed ID: 22435369
[TBL] [Abstract][Full Text] [Related]
36. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study.
Mazighi M; Serfaty JM; Labreuche J; Laissy JP; Meseguer E; Lavallée PC; Cabrejo L; Slaoui T; Guidoux C; Lapergue B; Klein IF; Olivot JM; Abboud H; Simon O; Niclot P; Nifle C; Touboul PJ; Raphaeli G; Gohin C; Claeys ES; Amarenco P;
Lancet Neurol; 2009 Sep; 8(9):802-9. PubMed ID: 19647488
[TBL] [Abstract][Full Text] [Related]
37. Readministration of intravenous alteplase in acute ischemic stroke patients: case series and systematic review.
Qureshi AI; Malik AA; Freese M; Thompson MJ; Khan AA; Suri MF
Am J Emerg Med; 2015 Feb; 33(2):307.e1-4. PubMed ID: 25190550
[TBL] [Abstract][Full Text] [Related]
38. Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke.
Menon BK; Al-Ajlan FS; Najm M; Puig J; Castellanos M; Dowlatshahi D; Calleja A; Sohn SI; Ahn SH; Poppe A; Mikulik R; Asdaghi N; Field TS; Jin A; Asil T; Boulanger JM; Smith EE; Coutts SB; Barber PA; Bal S; Subramanian S; Mishra S; Trivedi A; Dey S; Eesa M; Sajobi T; Goyal M; Hill MD; Demchuk AM;
JAMA; 2018 Sep; 320(10):1017-1026. PubMed ID: 30208455
[TBL] [Abstract][Full Text] [Related]
39. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion.
Zaidat OO; Suarez JI; Santillan C; Sunshine JL; Tarr RW; Paras VH; Selman WR; Landis DM
Stroke; 2002 Jul; 33(7):1821-6. PubMed ID: 12105360
[TBL] [Abstract][Full Text] [Related]
40. Alteplase for Stroke With Unknown Onset Time in Chronic Kidney Disease: A Pooled Analysis of Individual Participant Data.
Miwa K; Koga M; Jensen M; Inoue M; Yoshimura S; Fukuda-Doi M; Boutitie F; Ma H; Ringleb PA; Wu O; Schwamm LH; Warach S; Hacke W; Davis SM; Donnan GA; Gerloff C; Thomalla G; Toyoda K;
Stroke; 2022 Nov; 53(11):3295-3303. PubMed ID: 35997023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
